Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 13 | 2020 | 966 | 2.560 |
Why?
|
| Alzheimer Disease | 7 | 2021 | 281 | 2.340 |
Why?
|
| Dementia | 7 | 2021 | 246 | 2.050 |
Why?
|
| Cognition | 6 | 2020 | 548 | 1.480 |
Why?
|
| Blood Pressure | 5 | 2018 | 866 | 0.910 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2021 | 1211 | 0.840 |
Why?
|
| Hypertension | 3 | 2021 | 983 | 0.750 |
Why?
|
| Hydroxycholesterols | 2 | 2013 | 2 | 0.740 |
Why?
|
| Disease Progression | 2 | 2014 | 590 | 0.730 |
Why?
|
| Insulin | 2 | 2015 | 359 | 0.720 |
Why?
|
| Autonomic Nervous System | 1 | 2020 | 50 | 0.610 |
Why?
|
| Cholesterol | 3 | 2020 | 258 | 0.590 |
Why?
|
| Heart | 1 | 2020 | 177 | 0.570 |
Why?
|
| Heart Rate | 1 | 2020 | 364 | 0.530 |
Why?
|
| Humans | 26 | 2021 | 32284 | 0.510 |
Why?
|
| Cerebrovascular Disorders | 2 | 2018 | 51 | 0.470 |
Why?
|
| Dementia, Vascular | 1 | 2015 | 9 | 0.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2018 | 1436 | 0.450 |
Why?
|
| Cohort Studies | 8 | 2020 | 1840 | 0.440 |
Why?
|
| African Americans | 2 | 2018 | 1335 | 0.440 |
Why?
|
| Brain Ischemia | 1 | 2016 | 158 | 0.430 |
Why?
|
| Carotid Artery, Common | 1 | 2014 | 48 | 0.430 |
Why?
|
| Male | 18 | 2020 | 19434 | 0.410 |
Why?
|
| Stroke | 2 | 2018 | 691 | 0.410 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 127 | 0.410 |
Why?
|
| Female | 17 | 2020 | 19954 | 0.400 |
Why?
|
| Biological Transport | 1 | 2013 | 73 | 0.400 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 3896 | 0.400 |
Why?
|
| Neuropsychological Tests | 4 | 2020 | 327 | 0.390 |
Why?
|
| Frontal Lobe | 1 | 2013 | 34 | 0.390 |
Why?
|
| Aged | 12 | 2020 | 10257 | 0.370 |
Why?
|
| Diabetes Complications | 3 | 2018 | 171 | 0.350 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 267 | 0.340 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 335 | 0.340 |
Why?
|
| Apolipoprotein E4 | 3 | 2018 | 56 | 0.320 |
Why?
|
| Aging | 2 | 2013 | 941 | 0.310 |
Why?
|
| Weight Loss | 1 | 2012 | 410 | 0.300 |
Why?
|
| Cognition Disorders | 3 | 2018 | 349 | 0.300 |
Why?
|
| Risk Factors | 5 | 2018 | 3938 | 0.300 |
Why?
|
| Age Factors | 3 | 2020 | 1179 | 0.290 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 1485 | 0.270 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2020 | 12 | 0.260 |
Why?
|
| Case-Control Studies | 3 | 2013 | 858 | 0.250 |
Why?
|
| Time Factors | 3 | 2020 | 2196 | 0.250 |
Why?
|
| Obesity | 2 | 2014 | 1108 | 0.240 |
Why?
|
| Middle Aged | 8 | 2020 | 11843 | 0.230 |
Why?
|
| Positron-Emission Tomography | 4 | 2020 | 167 | 0.230 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1159 | 0.230 |
Why?
|
| Ankle Brachial Index | 2 | 2014 | 38 | 0.200 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 880 | 0.200 |
Why?
|
| Double-Blind Method | 2 | 2014 | 566 | 0.180 |
Why?
|
| Organ Size | 2 | 2018 | 221 | 0.150 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 181 | 0.150 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 170 | 0.150 |
Why?
|
| Triglycerides | 1 | 2020 | 234 | 0.150 |
Why?
|
| Mental Health | 1 | 2020 | 113 | 0.150 |
Why?
|
| Animals | 3 | 2015 | 8165 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 54 | 0.140 |
Why?
|
| Hypotension, Orthostatic | 1 | 2018 | 12 | 0.140 |
Why?
|
| Vascular Diseases | 1 | 2019 | 66 | 0.140 |
Why?
|
| Memory | 1 | 2020 | 202 | 0.140 |
Why?
|
| Amyloid | 1 | 2018 | 15 | 0.130 |
Why?
|
| Health Status | 1 | 2020 | 356 | 0.130 |
Why?
|
| Energy Metabolism | 1 | 2018 | 150 | 0.130 |
Why?
|
| Risk | 1 | 2018 | 305 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2018 | 3612 | 0.130 |
Why?
|
| Mitochondria | 1 | 2018 | 207 | 0.120 |
Why?
|
| United States | 3 | 2020 | 4079 | 0.120 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 122 | 0.120 |
Why?
|
| Atrophy | 2 | 2013 | 46 | 0.120 |
Why?
|
| Prognosis | 1 | 2020 | 1529 | 0.120 |
Why?
|
| Acute Disease | 1 | 2016 | 253 | 0.110 |
Why?
|
| Ethnic Groups | 1 | 2018 | 450 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 650 | 0.110 |
Why?
|
| Electrocardiography | 1 | 2020 | 624 | 0.110 |
Why?
|
| Glucose | 1 | 2015 | 158 | 0.110 |
Why?
|
| Prediabetic State | 1 | 2015 | 76 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2020 | 2320 | 0.110 |
Why?
|
| Inflammation | 1 | 2018 | 500 | 0.110 |
Why?
|
| Receptor, EphA1 | 1 | 2013 | 2 | 0.100 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 26 | 0.100 |
Why?
|
| Ginkgo biloba | 1 | 2013 | 20 | 0.100 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 27 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 58 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2013 | 273 | 0.100 |
Why?
|
| Plant Extracts | 1 | 2013 | 61 | 0.100 |
Why?
|
| Homeostasis | 1 | 2013 | 130 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 2238 | 0.100 |
Why?
|
| Overweight | 1 | 2014 | 252 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2015 | 457 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 364 | 0.090 |
Why?
|
| Pennsylvania | 1 | 2012 | 80 | 0.090 |
Why?
|
| Fasting | 1 | 2012 | 88 | 0.090 |
Why?
|
| Adult | 3 | 2014 | 9263 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2012 | 131 | 0.090 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 760 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2018 | 806 | 0.090 |
Why?
|
| Brain Infarction | 1 | 2011 | 10 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 426 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2012 | 863 | 0.070 |
Why?
|
| Young Adult | 1 | 2012 | 2652 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2012 | 3410 | 0.050 |
Why?
|
| Incidence | 2 | 2018 | 1244 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 45 | 0.040 |
Why?
|
| Cerebral Angiography | 1 | 2020 | 60 | 0.040 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2019 | 8 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 52 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 93 | 0.030 |
Why?
|
| Arteriosclerosis | 1 | 2018 | 143 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 63 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 174 | 0.030 |
Why?
|
| Age Distribution | 1 | 2018 | 194 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 99 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2018 | 179 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 226 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 368 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 773 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 851 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 470 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 1424 | 0.020 |
Why?
|
| Neurofibrillary Tangles | 1 | 2011 | 4 | 0.020 |
Why?
|
| Hawaii | 1 | 2011 | 5 | 0.020 |
Why?
|
| Autopsy | 1 | 2011 | 37 | 0.020 |
Why?
|
| Asian Americans | 1 | 2011 | 92 | 0.020 |
Why?
|